Skip to main content

Vitamin B3 Shows Promise in Treating Fatty Liver Disease

Published on June 23, 2026, 5:37 p.m.
Vitamin B3 Shows Promise in Treating Fatty Liver Disease

Topic: Health

Researchers have found a common vitamin that can help treat fatty liver disease. The vitamin, called niacin or vitamin B3, has been shown to reduce fat buildup and inflammation in the liver.

Fatty liver disease is a common condition that affects about 30% of people worldwide. It's characterized by excess fat accumulation in the liver, which can lead to serious health problems if left untreated. Now, scientists have made a breakthrough discovery that could lead to more effective treatments for this condition.

A team of international researchers led by Professor Jang Hyun Choi at UNIST has identified a key genetic factor that worsens fatty liver disease. This factor is called microRNA-93 (miR-93), and it's found in liver cells. The researchers discovered that miR-93 drives fat buildup, inflammation, and scarring in the liver by suppressing SIRT1, a gene that plays a key role in managing fat metabolism.

To better understand the role of miR-93, the team used gene editing to stop its production in mice. These animals showed significantly less fat accumulation in the liver, along with improved insulin sensitivity and better overall liver function. In contrast, mice engineered to produce excess miR-93 experienced more severe metabolic problems in the liver.

The researchers then screened 150 FDA-approved drugs to see if any could reduce miR-93 levels. Niacin (vitamin B3) stood out as the most effective option. In mice treated with niacin, miR-93 levels dropped sharply, while SIRT1 activity increased. This helped restore normal fat-processing pathways in the liver and improved overall lipid balance.

The study's findings have significant implications for the treatment of fatty liver disease. The researchers believe that niacin could be used as a potential treatment option, given its established safety record and availability.

Why It Matters

This breakthrough has important implications for public health in India, where fatty liver disease is becoming increasingly common due to changes in diet and lifestyle. A safe and effective treatment option like vitamin B3 could help prevent serious health complications and improve quality of life for millions of people.

Key Facts

  • Fatty liver disease affects about 30% of people worldwide.
  • MicroRNA-93 (miR-93) is a key genetic factor that worsens fatty liver disease.
  • Niacin (vitamin B3) has been shown to reduce miR-93 levels and improve liver function in mice.
  • The study's findings have significant implications for the treatment of fatty liver disease.

Key Terms

MicroRNA
A small RNA molecule that helps regulate gene activity

Implications

This breakthrough has important implications for public health in India, where fatty liver disease is becoming increasingly common due to changes in diet and lifestyle. A safe and effective treatment option like vitamin B3 could help prevent serious health complications and improve quality of life for millions of people.


Source: https://www.sciencedaily.com/releases/2026/03/260324080203.htm

Journal Reference:

  1. Yo Han Lee, Jinyoung Lee, Joonho Jeong, Kieun Park, Bukyung Baik, Yuseong Kwon, Kimyeong Kim, Keon Woo Khim, Haneul Ji, Ji Young Lee, Kwangho Kim, Ji Won Kim, Tam Dao, Misung Kim, Tae Young Lee, Yong Ryoul Yang, Haejin Yoon, Dongryeol Ryu, Seonghwan Hwang, Haeseung Lee, Dougu Nam, Won Kon Kim, Neung Hwa Park, Hwayoung Yun, Jang Hyun Choi. Hepatic miR-93 promotes the pathogenesis of metabolic dysfunction-associated steatotic liver disease by suppressing SIRT1. Metabolism, 2025; 169: 156266 DOI: 10.1016/j.metabol.2025.156266

Leave a Comment

Name
Email
Body
... ...

Get Exclusive Insights

with Every Issue

JoinShalyamNewsletter

Stay ahead in education, research, and innovation—straight to your inbox.